Cascara Sagrada 5,000 mg
On sale on the US market (according to the DSLD)
Nature's Answer, food supplement from the US market
Cascara Sagrada 5,000 mg (Nature's Answer), a food supplement au code-barres 083000001871, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Frangula purshiana Cooper: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes ainsi qu'une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Nature's Answer
- Barcode
- 083000001871
- Form
- Liquid
- One serving
- 5 teaspoons
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- None
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Compound Fluid Extract Cascara Sagrada Bark (Frangula purshiana) | Plant | 5,000 mg |
| Glycerin | Other | not stated |
| Organic Alcohol 18-20% | Other substance | not stated |
| Water | Other | not stated |
| Cascara Sagrada bark extract (Frangula purshiana) | Plant | not stated |
| Licorice root extract | Plant | not stated |
| Stevia leaf extract (Stevia rebaudiana) | Plant | not stated |
| Star Anise oil | Plant | not stated |
| Coriander seed Oil (Coriandrum sativum) | Plant | not stated |
| Wintergreen Oil (Gaultheria procumbens) | Plant | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Cascara Sagrada 5,000 mg
Entered into DSLD on 22 May 2016. Withdrawn from the US market on 1 April 2015 (according to the DSLD).- Active ingredient removed : Cascara Sagrada bark extract (quantity not stated)
- Active ingredient removed : Coriander seed Oil (quantity not stated)
- Active ingredient removed : Glycerin (quantity not stated)
- Active ingredient removed : Licorice root extract (quantity not stated)
- Active ingredient removed : Organic Alcohol 18-20% (quantity not stated)
- Active ingredient removed : Star Anise oil (quantity not stated)
- Active ingredient removed : Stevia leaf extract (quantity not stated)
- Active ingredient removed : Water (quantity not stated)
- Active ingredient removed : Wintergreen Oil (quantity not stated)
- Same quantity, different name: Cascara Sagrada (Rhamnus purshiana) bark extract in this version; Compound Fluid Extract Cascara Sagrada Bark on the displayed label (5,000 mg)
Official label: Cascara Sagrada Bark, Aromatic
Entered into DSLD on 21 December 2012. Withdrawn from the US market on 1 February 2015 (according to the DSLD).- Active ingredient removed : Compound Fluid Extract Cascara Sagrada Bark (5,000 mg)
- Active ingredient removed : Coriander seed Oil (quantity not stated)
- Active ingredient removed : Glycerin (quantity not stated)
- Active ingredient removed : Licorice root extract (quantity not stated)
- Active ingredient removed : Organic Alcohol 18-20% (quantity not stated)
- Active ingredient removed : Star Anise oil (quantity not stated)
- Active ingredient removed : Stevia leaf extract (quantity not stated)
- Active ingredient removed : Water (quantity not stated)
- Active ingredient removed : Wintergreen Oil (quantity not stated)
- Different unit, without conversion : Cascara Sagrada bark extract: 5,000 mg in this version; quantity not stated on the displayed label
Official label: Cascara Sagrada Bark, Aromatic
Entered into DSLD on 25 July 2012. Withdrawn from the US market on 1 June 2012 (according to the DSLD).- Active ingredient removed : Compound Fluid Extract Cascara Sagrada Bark (5,000 mg)
- Active ingredient removed : Coriander seed Oil (quantity not stated)
- Active ingredient removed : Glycerin (quantity not stated)
- Active ingredient removed : Licorice root extract (quantity not stated)
- Active ingredient removed : Organic Alcohol 18-20% (quantity not stated)
- Active ingredient removed : Star Anise oil (quantity not stated)
- Active ingredient removed : Stevia leaf extract (quantity not stated)
- Active ingredient removed : Water (quantity not stated)
- Active ingredient removed : Wintergreen Oil (quantity not stated)
- Different unit, without conversion : Cascara Sagrada bark extract: 5,000 mg in this version; quantity not stated on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Compound Fluid Extract Cascara Sagrada Bark
Read the warning, when it applies and the studies cited
CASCARA SAGRADA - FRANGULA PURSHIANA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder or a lazy bowel (EMA 2020; Brinker 2010; WHO 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking heart medications, corticosteroids, diuretics, or other health products that may contribute to electrolyte imbalance (EMA 2020; Brinker 2010; WHO 2002; Blumenthal et al. 2000).
Sources cited by Health Canada (5)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Contraindications
Do not use if you are pregnant or breastfeeding (EMA 2020; Brinker 2010; Blumenthal et al. 2000).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
Do not use if you have inflammatory bowel disease, fever or any undiagnosed gastrointestinal trouble (EMA 2020; Brinker 2010; WHO 2002).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
- WHO 2002: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 2. Geneva (CHE): World Health Organization; 2002.
- OMS 2002: Organisation mondiale de la Santé. WHO Monographs on Selected Medicinal Plants, Volume 2. Genève (CHE) : Organisation mondiale de la Santé; 2002.
Known adverse reactions
Stop use if hypersensitivity/allergy or diarrhea occurs (EMA 2020; Brinker 2010).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2020. European Medicines Agency. Community Herbal Monograph on Rhamnus Purshianus D.C., cortex. London (UK): EMA Committee on Herbal Medicinal Products (HMPC), 15 January 2020. [Accessed 2024 January 12]. Available from: https://www.fitoterapia.net/archivos/201811/final-community-herbal-monograph-rhamnus-purshianus-dc-cortex_en.pdf?1
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Nature's Answer
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Cascara Sagrada 5,000 mg (Nature's Answer): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/83000001871-cascara-sagrada-5-000-mg-nature-s-answer, updated 22 April 2016.